SeekingAlphaOctober 24, 2026 at 10:22 PM NY2 Days Ago
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3
Avalo's positive LOTUS results now support a pivotal trial, and its monthly dosing gives it a potential differentiating factor in HS. Read why AVTX stock is a Buy.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
